What Are the Problems?: Why Is It in the Economic Interest of OECD Countries to Address these Problems?
This chapter outlines the impact of neglected infectious diseases in developing countries by citing current morbidity and mortality rates, elucidating the economic burden infectious diseases pose, highlighting the problems of lacking pharmaceutical products, explaining the drug research and development/innovation process, and discussing the economics of drug development. The chapter closes with a section on why OECD is interested in neglected and emerging infectious diseases that mainly affect developing countries.
No Supplementary Data
No Article Media
Document Type: Review Article
Publication date: 01 April 2009